Fig. 1From: Development of a new fusion-enhanced oncolytic immunotherapy platform based on herpes simplex virus type 1Schematic representation of the viruses constructed in this study. The genome structures of the viruses constructed and tested. The construction of each virus is described in detail in the Additional file 1Back to article page